Essais liés5clinical trials
VilleSleepy Hollowlocalisation
PaysUnited Stateslocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT05673148

Ouvrir le site du centre

Essais cliniques associés

5
MoléculeIndication / populationPhaseNCTTitreStatut
Bevacizumab Cancer Phase 3 NCT07198074 Testing the Addition of an Antiangiogenic Drug (Bevacizumab) to Chemotherapy (Carboplatin and Paclitaxel) Combined With Immunotherapy (Pembrolizumab) for pMMR, TP53 Mutated Endometrial Cancer RECRUITING
Stereotactic Ablative Radiotherapy Cancer Phase 2 NCT05673148 Testing the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, ERASur Trial RECRUITING
Biospecimen Collection Cancer Phase 3 NCT06058377 Adding an Immunotherapy Drug, MEDI4736 (Durvalumab), to the Usual Chemotherapy Treatment (Paclitaxel, Cyclophosphamide, and Doxorubicin) for Stage II-III Breast Cancer RECRUITING
Biospecimen Collection Cancer Phase 3 NCT04267848 Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) RECRUITING
Biospecimen Collection Cancer Phase 2/3 NCT06203600 Adding Nivolumab to Usual Treatment for People With Advanced Stomach or Esophageal Cancer, PARAMUNE Trial RECRUITING